References
- Epstein O, Kato Y, Dick R, Sherlock Vitamin S. Dhydroxyapatite and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary biliary cirrhosis. Am J Clin Nutr 1982; 36: 426–30
- Compston JE. Hepatic osteodystrophy; vitamin D metabolism in patients with liver disease. Gut 1986; 27: 1073–90
- Fonseca V, Epstein O, Gill D S, Menon R K, Thomas M, McIntyre N, et al. Hyperparathyroidism and low osteocalcin despite vitamin D replacement in primary biliary cirrhosis. J Clin Endocrinol Metab 1987; 64: 873–7
- Berkum V FNR, Beukers R, Birkenhager J C, Kooij P PM, Schalm S W, Pols H AP. Bone mass in women with primary biliary cirrhosis; the relation with histologic stage and use of glucocorticoids. Gastroenterology 1990; 99: 1134–9
- Diamond T H, Stiel D, Lunzer M, McDowall D, Eckstein R P, Posen S. Hepatic osteodystrophy. Static and dynamic histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease. Gastroenterology 1989; 96: 213–21
- McDonald J A, Dunstan C R, Dilworth P, Sherbon K, Ross Sheil A G, Evans R A, et al. Bone loss after liver transplantation. Hepatology 1991; 14: 613–9
- Eastell R, Dickson E R, Hodgson S F, Weisner R H, Porayko M K, Wahner H W, et al. Rate of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 1991; 14: 296–300
- Porayko M K, Wiesner R H, Krom R AF, Dickson E R, Beaver S, Schwerman L. Bone disease in liver transplant recipients: incidence, timing, and risk factors. Transplant Proc 1991; 23: 1462–5
- Lopez M B, Gonzalez Pinto I, Hawkins F, Valero M A, Leon M, Loinaz C, et al. Effect of liver transplantation and immunosuppressive treatment on bone mineral density. Transplant Proc 1992; 24: 3044–6
- Rigs B L, Wahner W, Dunn W L, Mazess R B, Offord K P, Melton W, III. Differential changes in bone mineral density of the appendicular and axial skeleton with ageing. J Clin Invest 1981; 67: 328–35
- Mazess R B, Ort M, Judy P, Mather W. Absorptiometric bone mineral determination using 153Gd. Proceedings, Bone Measurement Conference., J R Ameron. Clearing House for Federal Scientific and Technical Information, Springfield (IL) 1974; 308–12, US Atomic Energy Commission Conference 700515.
- Cameron J R, Sorensen JA. Measurement of bone mineral in vivo: an improved method. Science 1964; 142: 230–2
- Eriksson S AV, Isberg B O, Lindgren JU. Prediction of vertebral strength by dual photon absorptiometry and quantitative computed tomography. Calcif Tissue Int 1989; 44: 243–50
- Matloff D S, Kaplan M M, Neer R M, Goldberg U I, Bitman W, Wolfe HJ. Osteoporosis in primary biliary cirrhosis: effect of 25 hydroxyvitamin D3 treatment. Gastroenterology 1982; 83: 97–102
- Long R G, Meinhard E, Skinner R K, Varghese Z, Wills M R, Sherlock S. Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease. Gut 1978; 19: 85–90
- Stellon A J, Webb A, Compston J, Williams R. Low born turnover state in primary biliary cirrhosis. Hepatology 1978; 7: 137–42
- Hodgson S F, Dickson E R, Wahner H W, Johnson K A, Mann K G, Riggs BL. Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 1985; 103: 855–60
- Jorge-Hernandez J A, Gonzalez-Reimers C E, Torres-Ramirez A, Santolaria-Fernandez F, Gonzalez-Garcia C, Batista-Lopez J N, et al. Bone changes in alcoholic liver cirrhosis. A histomorpho-metrical analysis of 52 cases. Dig Dis Sci 1988; 33: 1089–95
- Floreani A, Chiaramonte M, Giannini S, Malvasi L, Lodetti M G, Castrignano R, et al. Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study on calcitonin treatment. J Hepatol 1991; 12217–23
- Steinberg K K, Bonkovsky H L, Caudill S P, Bernhardt R K, Hawkins M. Osteocalcin and bone alkaline phosphatase in serum of women with liver disease. Ann Clin Lab Sci 1991; 21: 305–14
- Pietschmann P, Resch H, Ch Muller, Woloszczuk W, Will-Vonseder R. Decreased serum osteocalcin levels in patients with liver disease. Bone Mineral 1990; 8: 103–8
- Kelly P J, Sambrook P N, Eisman JA. Potential protection by cyclosporine against glucocorticoid effects on bone. Lancet 1989; 2: 1388
- Aubia J, Masramon J, Serrano S, Lloveras J, Marinoso LL. Bone histology in renal transplant patients receiving cyclosporine. Lancet 1988; 1: 1048